Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

Jairo A. Garcia, Lewis Rowland Roberts

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)486-487
Number of pages2
JournalJournal of Hepatology
Volume56
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Hepatocellular Carcinoma
Therapeutics
brivanib

ASJC Scopus subject areas

  • Hepatology

Cite this

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma. / Garcia, Jairo A.; Roberts, Lewis Rowland.

In: Journal of Hepatology, Vol. 56, No. 2, 02.2012, p. 486-487.

Research output: Contribution to journalArticle

@article{37b0de0ebfa24a16934e1445160b8a34,
title = "Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma",
author = "Garcia, {Jairo A.} and Roberts, {Lewis Rowland}",
year = "2012",
month = "2",
doi = "10.1016/j.jhep.2011.07.033",
language = "English (US)",
volume = "56",
pages = "486--487",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

AU - Garcia, Jairo A.

AU - Roberts, Lewis Rowland

PY - 2012/2

Y1 - 2012/2

UR - http://www.scopus.com/inward/record.url?scp=84855979959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855979959&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2011.07.033

DO - 10.1016/j.jhep.2011.07.033

M3 - Article

VL - 56

SP - 486

EP - 487

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 2

ER -